Share this article
Share this article
ResearchAndMarkets.com s offering.
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Europe Cell and Gene Therapy Market Report
The Europe cell and gene therapy market by revenue is expected to grow at a CAGR of over 23% during the period 2021-2026.
The global cell and gene therapy market is observing significant mergers and acquisition activities, product sales, and new market authorizations. In 2026, the market is expected to grow almost four times more than the current value, with new product approvals expected annually.
Although initial product approvals have been for relatively small patient groups, the significant pipeline of cell & gene therapy studies for diseases such as hemophilia and various forms of blindness will significantly expand. In addition, the Europe market is witnessing steady growth due to the increased availability of funds from several public and private institutes.
ThermoGenesis Holdings Begins a Year of Celebration of its 35th Anniversary in the Cell Banking and Cell Therapy Industry
Future corporate strategy targets large-scale cellular manufacturing needs for upcoming cell and gene therapies
News provided by
Share this article
Share this article
RANCHO CORDOVA, Calif., Feb. 17, 2021 /PRNewswire/ ThermoGenesis Holdings, Inc. ( ThermoGenesis or the Company ) (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that the Company will kick off a year of celebration of its 35th anniversary by aligning its future corporate strategy in offering cell processing systems and services to meet the large-scale cellular manufacturing needs of the increasing number of therapies to be developed over the next decade.
Azzur Labs Establishes New Location in Dallas under the Direction of Anita Boye
Anita Boye is appointed as Senior Director of Azzur Labs Dallas, leading the organization s newest analytical laboratory serving the biopharmaceutical and medical device industries
News provided by
Share this article
DALLAS, Feb. 17, 2021 /PRNewswire/
Azzur Labs, an Azzur Group company, today announces the establishment of its newest analytical laboratory, located in Dallas, Texas.
Azzur Labs, headquartered in Lehigh Valley, PA, specializes in analytical testing necessary to help biopharmaceutical, medical device, and health care businesses start, scale, and sustain their GxP organizations. Azzur Labs Dallas was established to specifically meet the needs of the burgeoning life science industry in the Lone Star State.
Business Leader And Philanthropist Ken Langone Joins RADical Hope Board Of Directors
Champions Youth Wellness, Resilience Through Innovative Programs
News provided by
Share this article
NEW YORK, Feb. 17, 2021 /PRNewswire/
American businessman, investor and philanthropist Ken Langone has joined the Board of Directors of RADical Hope, a foundation dedicated to improving the lives and futures of young adults by strengthening connections and building resilience.
RADical Hope was established in 2018 following the tragic death of Chris Martin, a Gonzaga University junior. The Foundation develops and invests in programs that teach fundamental skills to enhance the mental, physical and emotional health of young Americans so they re better equipped to cope with 21st-Century challenges. Suicide is the second leading cause of death in the U.S. for those between the ages of 17 and 24.
Blue KC Offers Affordable Health Plans Through the ACA Marketplace During A New 2021 Special Enrollment Period
Blue KC making comprehensive and affordable ACA plans available through May 15, 2021
News provided by
Share this article
Share this article
KANSAS CITY, Mo., Feb. 15, 2021 /PRNewswire/ Blue Cross and Blue Shield of Kansas City (Blue KC), the region s largest not-for-profit healthcare insurance provider, is offering individual Affordable Care Act (ACA) plans for 2021, which are now available to Marketplace-eligible consumers during a new Special Enrollment Period (SEP) beginning February 15 and running through May 15, 2021.
The SEP is available in accordance with the Executive Order that President Biden issued on January 28, 2021, in response to the COVID-19 Public Health Emergency. Millions of Americans are facing uncertainty and exceptional circumstances, including high levels of unemployment coupled with a rise in health conditions, and this SEP offers an additio